Miyelin Oligodendrosit Glikoprotein (MOG) ile İlişkili Bozukluklar

De Mol C, Wong Y, Van Pelt E, Wokke B, Siepman T, Neuteboom R, vd. The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults. Mult Scler. Haziran 2020;26(7):806-14.

Nagireddy RBR, Kumar A, Singh VK, Prasad R, Pathak A, Chaurasia RN, vd. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature. Journal of Neuroimmunology. Aralık 2021;361:577742.

Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N, vd. Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide. Front Neurol. 26 Haziran 2020;11:501.

Waters P, Woodhall M, O’Connor KC, Reindl M, Lang B, Sato DK, vd. MOG cell-based assay detects non-MS patients with inflammatory neurologic disease. Neurol Neuroimmunol Neuroinflamm. Haziran 2015;2(3):e89.

Gklinos P, Dobson R. Myelin Oligodendrocyte Glycoprotein-Antibody Associated Disease: An Updated Review of the Clinical Spectrum, Pathogenetic Mechanisms and Therapeutic Management. Antibodies. 17 Mayıs 2024;13(2):43.

Brill L, Ganelin-Cohen E, Dabby R, Rabinowicz S, Zohar-Dayan E, Rein N, vd. Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel. Front Neurol. 21 Ocak 2021;11:612304.

Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, vd. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain. 01 Aralık 2017;140(12):3128-38.

Boesen MS, Jensen PEH, Born AP, Magyari M, Nilsson AC, Hoei-Hansen C, vd. Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study. Multiple Sclerosis and Related Disorders. Ağustos 2019;33:162-7.

Cobo-Calvo A, Ruiz A, Maillart E, Audoin B, Zephir H, Bourre B, vd. Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study. Neurology [Internet]. 22 Mayıs 2018 [a.yer 10 Eylül 2024];90(21). Erişim adresi: https://www.neurology.org/doi/10.1212/WNL.0000000000005560

Cobo‐Calvo A, Ruiz A, Rollot F, Arrambide G, Deschamps R, Maillart E, vd. Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease. Annals of Neurology. Ocak 2021;89(1):30-41.

Waters P, Fadda G, Woodhall M, O’Mahony J, Brown RA, Castro DA, vd. Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes. JAMA Neurol. 01 Ocak 2020;77(1):82.

Hyun JW, Woodhall MR, Kim SH, Jeong IH, Kong B, Kim G, vd. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases. J Neurol Neurosurg Psychiatry. Ekim 2017;88(10):811-7.

Amano H, Miyamoto N, Shimura H, Sato DK, Fujihara K, Ueno S, vd. Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report. BMC Neurol. Aralık 2014;14(1):224.

Nakamura Y, Nakajima H, Tani H, Hosokawa T, Ishida S, Kimura F, vd. Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report. BMC Neurol. Aralık 2017;17(1):76.

Vieira JP, Sequeira J, Brito MJ. Postinfectious Anti–Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis. J Child Neurol. Ekim 2017;32(12):996-9.

Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, vd. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 01 Mayıs 2020;143(5):1431-46.

Höftberger R, Guo Y, Flanagan EP, Lopez-Chiriboga AS, Endmayr V, Hochmeister S, vd. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody. Acta Neuropathol. Mayıs 2020;139(5):875-92.

Takai Y, Misu T, Fujihara K, Aoki M. Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders. Front Neurol. 21 Temmuz 2023;14:1209749.

Popescu BFGh, Lucchinetti CF. Pathology of Demyelinating Diseases. Annu Rev Pathol Mech Dis. 28 Şubat 2012;7(1):185-217.

Hohlfeld R, Dornmair K, Meinl E, Wekerle H. The search for the target antigens of multiple sclerosis, part 2: CD8+ T cells, B cells, and antibodies in the focus of reverse-translational research. The Lancet Neurology. Mart 2016;15(3):317-31.

Machado-Santos J, Saji E, Tröscher AR, Paunovic M, Liblau R, Gabriely G, vd. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain. 01 Temmuz 2018;141(7):2066-82.

Longbrake E. Myelin Oligodendrocyte Glycoprotein–Associated Disorders. CONTINUUM: Lifelong Learning in Neurology. Ağustos 2022;28(4):1171-93.

Asseyer S, Hamblin J, Messina S, Mariano R, Siebert N, Everett R, vd. Prodromal headache in MOG-antibody positive optic neuritis. Multiple Sclerosis and Related Disorders. Mayıs 2020;40:101965.

in cooperation with the Neuromyelitis Optica Study Group (NEMOS), Pache F, Zimmermann H, Mikolajczak J, Schumacher S, Lacheta A, vd. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. J Neuroinflammation. Aralık 2016;13(1):282.

Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga A (Sebastian) S, Fryer JP, Leavitt JA, vd. Myelin Oligodendrocyte Glycoprotein Antibody–Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome. American Journal of Ophthalmology. Kasım 2018;195:8-15.

Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, vd. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm. Aralık 2015;2(6):e163.

Chen JJ, Bhatti MT. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis. Current Opinion in Neurology. Şubat 2020;33(1):47-54.

Pakeerathan T, Havla J, Schwake C, Salmen A, Bigi S, Abegg M, vd. Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode. J Neurol. Aralık 2022;269(12):6366-76.

Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G, vd. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain. Mart 2017;140(3):617-27.

Dubey D, Pittock SJ, Krecke KN, Morris PP, Sechi E, Zalewski NL, vd. Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody. JAMA Neurol. 01 Mart 2019;76(3):301.

Martinez-Hernandez E, Guasp M, García-Serra A, Maudes E, Ariño H, Sepulveda M, vd. Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies. Neurology [Internet]. 02 Haziran 2020 [a.yer 12 Eylül 2024];94(22). Erişim adresi: https://www.neurology.org/doi/10.1212/WNL.0000000000009239

Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, vd. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. The Lancet Neurology. Mart 2023;22(3):268-82.

Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, vd. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. Nisan 2016;22(4):470-82.

Banks SA, Morris PP, Chen JJ, Pittock SJ, Sechi E, Kunchok A, vd. Brainstem and cerebellar involvement in MOG-IgG-associated disorder versus aquaporin-4-IgG and MS. J Neurol Neurosurg Psychiatry. Nisan 2021;92(4):384-90.

Lechner C, Baumann M, Hennes EM, Schanda K, Marquard K, Karenfort M, vd. Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease. J Neurol Neurosurg Psychiatry. Ağustos 2016;87(8):897-905.

Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, vd. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. Eylül 2013;19(10):1261-7.

Bruijstens AL, Wendel EM, Lechner C, Bartels F, Finke C, Breu M, vd. E.U. paediatric MOG consortium consensus: Part 5 – Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European Journal of Paediatric Neurology. Kasım 2020;29:41-53.

Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, vd. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology. 29 Ağustos 2017;89(9):900-8.

Huppke P, Rostasy K, Karenfort M, Huppke B, Seidl R, Leiz S, vd. Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients. Mult Scler. Haziran 2013;19(7):941-6.

Wong YYM, Hacohen Y, Armangue T, Wassmer E, Verhelst H, Hemingway C, vd. Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome. Euro J of Neurology. Mayıs 2018;25(5):782-6.

Chalmoukou K, Alexopoulos H, Akrivou S, Stathopoulos P, Reindl M, Dalakas MC. Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm. Ağustos 2015;2(4):e131.

López-Chiriboga AS, Majed M, Fryer J, Dubey D, McKeon A, Flanagan EP, vd. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders. JAMA Neurol. 01 Kasım 2018;75(11):1355.

Lock JH, Newman NJ, Biousse V, Peragallo JH. Update on pediatric optic neuritis. Current Opinion in Ophthalmology. Kasım 2019;30(6):418-25.

Narayan RN, McCreary M, Conger D, Wang C, Greenberg BM. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients. Multiple Sclerosis and Related Disorders. Şubat 2019;28:86-90.

Hacohen Y, Mankad K, Chong WK, Barkhof F, Vincent A, Lim M, vd. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children. Neurology. 18 Temmuz 2017;89(3):269-78.

Bruijstens AL, Breu M, Wendel EM, Wassmer E, Lim M, Neuteboom RF, vd. E.U. paediatric MOG consortium consensus: Part 4 – Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European Journal of Paediatric Neurology. Kasım 2020;29:32-40.

Hintzen RQ, Dale RC, Neuteboom RF, Mar S, Banwell B. Pediatric acquired CNS demyelinating syndromes: Features associated with multiple sclerosis. Neurology [Internet]. 30 Ağustos 2016 [a.yer 09 Eylül 2024];87(9_Supplement_2). Erişim adresi: https://www.neurology.org/doi/10.1212/WNL.0000000000002881

O’Connell K, Hamilton-Shield A, Woodhall M, Messina S, Mariano R, Waters P, vd. Prevalence and incidence of neuromyelitis optica spectrum disorder, aquaporin-4 antibody-positive NMOSD and MOG antibody-positive disease in Oxfordshire, UK. J Neurol Neurosurg Psychiatry. Ekim 2020;91(10):1126-8.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, vd. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet Neurology. Şubat 2018;17(2):162-73.

Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, vd. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. Şubat 2018;89(2):127-37.